JosephRobertVolpicelliMDPh.D.
Psychiatry • Plymouth Meeting, PAAddiction
Executive Director Institute of Addiction Medicine
Dr. Volpicelli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 Germantown Pike
Ste H2
Plymouth Meeting, PA 19462Phone+1 484-351-8031Fax+1 484-351-8073
Education & Training
University of Pennsylvania Health SystemResidency, Psychiatry, 1982 - 1985
St Luke's University HospitalInternship, Transitional Year, 1981 - 1982
Perelman School of Medicine at the University of PennsylvaniaClass of 1981
Certifications & Licensure
PA State Medical License 1982 - 2024- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Neurocognitive Functioning Following The PROMETA® Treatment Protocol In Subjects With Alcohol Dependence Start of enrollment: 2007 Mar 01
- OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder Start of enrollment: 2021 Jun 30
Roles: Contact
Publications & Presentations
PubMed
- 7 citationsRethinking Unhealthy Alcohol Use in the United States: A Structured Review.Joseph R Volpicelli, Percy Menzies
Substance Abuse. 2022-01-01 - 23 citationsHeterogeneity of nonadherent buprenorphine patients: subgroup characteristics and outcomes.Charles Ruetsch, Joseph Tkacz, Vijay R Nadipelli, Brenna L. Brady, Naoko A Ronquest
The American Journal of Managed Care. 2017-06-01 - 61 citationsRelationship Between Buprenorphine Adherence and Health Service Utilization and Costs Among Opioid Dependent Patients.Joseph Tkacz, Joseph R. Volpicelli, Hyong Un, Charles Ruetsch
Journal of Substance Abuse Treatment. 2014-04-01
Other
- Ambulatory alcohol detoxificationVolpicelli JR, Teitelbaum SA
http://www.uptodate.com/contents/ambulatory-alcohol-detoxification
UpToDate, Wolters Kluwer Health - 2013-03-12
Press Mentions
Opioid Addiction: Overdose Risk Increases After Pain Relievers Are DiscontinuedDecember 1st, 2022- In-Depth: Fighting the Deadly Growth of Opioid Overdoses During COVID-19August 31st, 2021
- Alkermes Launches New Disease State Website to Offer Education About Alcohol DependenceApril 29th, 2021
- Join now to see all
Grant Support
- Naltrexone Treatment Of Alcohol DependenceNational Institute On Alcohol Abuse And Alcoholism1992–2002
- Innovative Approaches For Cocaine PharmacotherapyNational Institute On Drug Abuse1999
- Rehabilitation For Cocaine Dependent New MothersNational Institute On Drug Abuse1996–1998
- Naltrexone Treatment Of Alcohol DependenceNational Institute On Alcohol Abuse And Alcoholism1989–1991
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
